Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Xilio Therapeutics, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/23/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
| 01/04/2022 |
4/A
| Russo Rene (CEO AND PRESIDENT) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $13.83, valued at
$1.4M
|
|
| 11/03/2021 |
4/A
| SV7 Impact Medicine Fund LP (10% Owner) has filed a Form 4 on Xilio Therapeutics, Inc.|
Txns:
| Converted 998,544 shares
@ $0
Converted 998,544 shares
@ $0
Converted 302,588 shares
@ $0
Converted 302,588 shares
@ $0
Bought 312,500 shares
@ $16, valued at
$5M
Bought 312,500 shares
@ $16, valued at
$5M
Converted 9,486,166 convertible preferred
@ $0
Converted 9,486,166 convertible preferred
@ $0
Converted 2,874,595 convertible preferred
@ $0
Converted 2,874,595 convertible preferred
@ $0 |
|
|
|